FDA Approves New COVID Vaccine
Digest more
The agency is changing the standard of evidence required for Covid-19 vaccine approval in the US, Dr. Vinay Prasad, the new director of the FDA’s Center for Biologics Evaluation and Research, and FDA Commissioner Dr. Marty Makary, said in an editorial published Tuesday in the New England Journal of Medicine
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of serious illness
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.
FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.”
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two related deaths, according to the FDA and CDC.
FDA set to change requirements to get vaccines approved as RFK Jr continues to push skepticism about their use - New FDA framework on changes coronavirus vaccine approval will be released “in the coming days,